Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,321 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

NCT00083603

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
  • Univ. of Rochester HVTN CRS Rochester, New York, United States
  • FHCRC/UW Vaccine CRS Seattle, Washington, United States
View Trial Details
Completed

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

NCT00069030

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Fenway Community Health Clinical Research Site (FCHCRS) Boston, Massachusetts, United States
  • NY Blood Ctr./Union Square CRS New York, United States
View Trial Details
Completed

Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052

NCT00091416

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore Baltimore, Maryland, United States
  • Fenway Community Health Clinical Research Site (FCHCRS) Boston, Massachusetts, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
  • HIV Prevention & Treatment CRS New York, United States
View Trial Details
Completed

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

NCT00054860

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Fenway Community Health Clinical Research Site (FCHCRS) Boston, Massachusetts, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
  • Miriam Hospital's HVTU Providence, Rhode Island, United States
View Trial Details
Completed

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

NCT00027365

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research, Project SAVE-Baltimore Baltimore, Maryland, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

NCT00011037

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Projeto Praça Onze/Hesfa Crs Rio de Janeiro, Brazil
  • Les Centres GHESKIO CRS Port-au-Prince, Haiti
  • Barranco CRS Lima, Peru
  • CCPRI Med. Ctr. - Med. Research Foundation of Trinidad & Tobago Port of Spain, Trinidad and Tobago
View Trial Details
Completed

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

NCT01423825

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details
Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

NCT00574600

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details

Related conditions